|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/198 | |
| A61P 25/28 | |||
| A61P 25/24 | |||
| A61P 25/14 | |||
| A61P 25/04 |
| (11) | Number of the document | 3228313 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17170079.2 |
| Date of filing the European patent application | 2014-01-22 | |
| (97) | Date of publication of the European application | 2017-10-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361849191 P | 2013-01-22 | US |
| (72) |
Snodgrass, Ralph H., US
Cato, Allen E., US
Hicklin, Jack S., US
|
| (73) |
Vistagen Therapeutics, Inc.,
343 Allerton Avenue, South San Francisco, CA 94080,
US
|
| (54) | DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE |
| DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE |